Nexsan Exceeds First Quarter Revenue Target and Announces Plans to Foster More Growth and Continued Innovation on Marquee SAN and File Storage Product Line
10.5.2023 16:00:00 EEST | Business Wire | Press release
Nexsan today announced that it surpassed its aggressive Q1 earnings target. After being acquired by Serene Investment Management LLC in February, Serene’s ownership has quickly steered Nexsan back into a stage of growth, innovation, and profitability.
Under this new ownership, Serene Investment Management LLC’s first order of business was to bring in experienced technology leaders to foster a new era of growth and deliver on the ownership’s vision of continued high-quality product innovation, delivery, and unrivaled customer satisfaction. One of those experienced technology leaders is Nexsan’s new CEO, Dan Shimmerman, who has a proven track record of success in delivering strategic vision, execution, and value for all stakeholders in enterprise technology.
“The future is incredibly bright for all of Nexsan which includes our loyal customers and partners,” explains Nexsan CEO, Dan Shimmerman. “Serene’s ownership is committed to investing in the business and fueling continuous growth. We’ve been given the vital capital we need to continue to innovate and deliver the highly-reliable, cost-effective data storage solutions that have been exceeding specific and crucial business demands for over 20 years.”
As part of the acquisition earlier this year, Serene retained key employees and leaders to ensure business continuity and deliver on Nexsan’s commitment to a seamless customer support experience. Throughout the acquisition and restructuring, Serene has been steadfastly committed to maintaining Nexsan’s high level of customer support which includes the support team’s global coverage and footprint.
In the interim, Nexsan negotiated strong strategic alliance agreements with their global partner network to stabilize supply chains and kick-start its continued service to all end customers and vendors.
Earlier in the month of April, Nexsan also attended the NAB (National Association of Broadcasters) Show Centennial in Las Vegas, Nevada to showcase the reliability, cost-effectiveness, and continued innovation on its marquee SAN and file storage product line that includes E-Series, Unity, and the exciting developments on its Assureon Data Vault.
For more information on Nexsan’s suite of enterprise storage products, see https://www.nexsan.com/products-landing/.
For more information on Nexsan’s core use cases, see https://www.nexsan.com/whats-your-business/.
About Nexsan®
Nexsan® is a global leader in enabling customers to securely store, protect and manage data. Established in 1999, Nexsan has earned a reputation for delivering the most highly reliable, secure and cost-effective storage, while always remaining agile in order to continuously deliver purpose-built storage and data management solutions that meet complex and everchanging IT, business and budgetary requirements. Nexsan’s patented technology is ideal for a variety of use cases including Financial, Healthcare and Life Sciences, Government, Military, Law Enforcement, Education, Media and Entertainment and Call Centers. For further information, please visit: www.nexsan.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230510005029/en/
Contact information
Matthew Pugh
443-527-1552
mpugh@pughandtillerpr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 20:15:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 17:00:00 EEST | Press release
Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 16:17:00 EEST | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market
Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 16:15:00 EEST | Press release
Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The valve features the company’s FREE next generation tissue treatment addressing the two main causes of calcification, phospholipids and aldehydes. Its proprietary LANCELOT advanced manufacturing process includes zero-pressure shaping and laser cutting of
Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale9.10.2026 16:00:00 EEST | Press release
Ada, the pioneer in Agentic Customer Experience, today announced it has achieved the Amazon Web Services (AWS) Travel and Hospitality Competency. The designation recognizes Ada as an AWS Partner with demonstrated technical proficiency and proven customer success helping travel and hospitality brands resolve customer issues at scale. Ada joins a select group of 58 AWS Partners holding the competency, and it reflects a shared commitment to helping travel brands deliver service that holds up on their busiest, most unpredictable days. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009673638/en/ Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale "Travel is where agentic customer service gets tested hardest. Demand spikes without warning, policies change by the hour, and customers are often stressed and far from home," said Mike Murchison, CEO and co-founder of Ada. "Our airline and hospitali
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom